Skip to content
Connected Health Initiative LogoConnected Health Initiative LogoConnected Health Initiative Logo
  • About CHI
  • Steering Committee
    • Get Involved
    • Working Groups
  • News
    • Blog
    • Statements
    • Letters
  • Filings
  • Resources
    • Publications
    • End of Year Reports
    • Digital Health Evidence Resource
    • Insights on COVID-19
  • Contact Us
  • About CHI
  • Steering Committee
    • Get Involved
    • Working Groups
  • News
    • Blog
    • Statements
    • Letters
  • Filings
  • Resources
    • Publications
    • End of Year Reports
    • Digital Health Evidence Resource
    • Insights on COVID-19
  • Contact Us

Comments of the Connected Health Initiative to the Food and Drug Administration, Draft Guidance for Industry and Food and Drug Administration Staff, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations [Docket No. FDA-2024-N-3924; 89 FR 76119]

  1. Home
  2. News
  3. Letters
  4. Comments of the Connected Health Initiative to the Food and Drug Administration, Draft Guidance for Industry and Food and Drug Administration Staff, Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations [Docket No. FDA-2024-N-3924; 89 FR 76119]

 

CHI Comments–FDA Draft Guidance re AI-Enabled Device Software Functions Lifecycle Mgmt and Marketing Submissions (7 Apr 2025)
Connected Health Initiative Logo

1401 K St. NW, Suite 501
Washington, D.C. 20005

Call us: 202-331-2130

Useful links

ABOUT CHI

STEERING COMMITTEE

NEWS

FILINGS

RESOURCES

ANTITRUST GUIDELINES

Get Involved

Get Involved

© Copyright Connected Health. All Rights Reserved.

  • Site Map
  • Terms of Service
  • Privacy Policy

Website Design and Development by Ironistic

Page load link

Name(Required)
Will you be attending this event virtually or in-person?

Go to Top